Zhejiang Huahai Pharmaceutical Co., Ltd. ( China (Mainland))

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. The company is entitled as National Key Hi-tech Enterprise, National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai is the first pharmaceutical company in China that has passed USA FDA approval.

Huahai Pharmaceuticals integrates fomulations, APIs and intermediates, developing both domestic and international markets. The company has 10 branches in the United States, Shanghai, Hangzhou, and Linhai.

Huahai Pharmaceuticals is the largest supplier of pril products worldwide with its dominating products "captopril" (62571-86-2) and "enalapril" (75847-73-3) both ranking first in the world. It is also the only manufacturer in the world that can enjoy the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D.

The company's workshops of formulation are designed with the international cGMP standard and introduced the most advanced automatic pharmaceutical production equipment in the world.